Tech Company Financing Transactions

NuMedii Funding Round

Claremont Creek Ventures, Life Science Angels and Lightspeed Venture Partners participated in a $3.5 million Series A funding round for NuMedii. The round was announced on 6/27/2013.

Transaction Overview

Company Name
Announced On
6/27/2013
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
66 Bovet Rd. 320
San Mateo, CA 94402
USA
Phone
Undisclosed
Email Address
Overview
NuMedii is initially using its Big Data technology to discover and de-risk new indications for safe, existing drugs. It plans to apply the same approach to discover and de-risk new molecular entities (NMEs) based on therapeutically relevant biological networks.
Profile
NuMedii LinkedIn Company Profile
Social Media
NuMedii Company Twitter Account
Company News
NuMedii News
Facebook
NuMedii on Facebook
YouTube
NuMedii on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gini Deshpande
  Gini Deshpande LinkedIn Profile  Gini Deshpande Twitter Account  Gini Deshpande News  Gini Deshpande on Facebook
VP - Product Management
Linda Young
  Linda Young LinkedIn Profile  Linda Young Twitter Account  Linda Young News  Linda Young on Facebook
VP - R & D
Heather Arnett
  Heather Arnett LinkedIn Profile  Heather Arnett Twitter Account  Heather Arnett News  Heather Arnett on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/27/2013: ConnecTV venture capital transaction
Next: 6/27/2013: Brit & Co venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary